Sign inGet started

Martin G. Kelly

Insider CIK 1591756 · RDUS CEO and President, Director · NOVN Interim Chief ExecutiveOfficer, Director · QCOR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RDUS Radius Health, Inc. D To issuer2022-08-152022-08-1575,000$10.00 $750.0K0SEC↗
RDUS Radius Health, Inc. A Award2022-02-212022-02-23960,000— $0960,000SEC↗
RDUS Radius Health, Inc. A Award2022-02-212022-02-2575,000— $075,000SEC↗
RDUS Radius Health, Inc. A Award deriv2021-02-222021-02-23460,000— $0460,000SEC↗
RDUS Radius Health, Inc. A Award deriv2021-02-222021-03-24460,000— $0460,000SEC↗
RDUS Radius Health, Inc. A Award deriv2020-04-282020-04-29575,000— $0575,000SEC↗
NOVN Novan, Inc. A Award deriv2019-07-312019-08-021,000,000— $01,000,000SEC↗
NOVN Novan, Inc. P Buy2019-05-292019-05-301,500$1.97 $3.0K45,000SEC↗
NOVN Novan, Inc. P Buy2019-05-282019-05-293,500$2.15 $7.5K43,500SEC↗
NOVN Novan, Inc. P Buy2019-05-172019-05-2120,000$1.43 $28.6K60,000SEC↗
NOVN Novan, Inc. P Buy2019-05-172019-05-2140,000$1.43 $57.2K40,000SEC↗
NOVN Novan, Inc. P Buy2018-09-262018-09-2710,000$2.73 $27.3K40,000SEC↗
NOVN Novan, Inc. P Buy2018-08-212018-08-2330,000$2.71 $81.3K30,000SEC↗
NOVN Novan, Inc. A Award deriv2017-06-052017-06-0734,014— $034,014SEC↗
NOVN Novan, Inc. A Award deriv2016-09-202016-09-2214,484— $014,484SEC↗
QCOR QUESTCOR PHARMACEUTICALS I D To issuer deriv2014-08-142014-08-181,160— $00SEC↗
QCOR QUESTCOR PHARMACEUTICALS I D To issuer2014-08-142014-08-182,812— $00SEC↗
QCOR QUESTCOR PHARMACEUTICALS I A Award deriv2013-11-092013-11-136,187— $06,187SEC↗
QCOR QUESTCOR PHARMACEUTICALS I A Award2013-11-092013-11-132,812— $02,812SEC↗